88IV - PR Newswire Asia's news - Biotechnology

< Previous page

| Title only | Print

Next page >

Gene Solutions Showcases Global Evidence and Responsible Innovation in Prenatal and Women's Genomic Health at ISPD 2026 As a Premier Partner, Gene Solutions presented Asia-led real-world evidence from large-scale NIPT-integrated carrier screening, alongside advances in AI-enabled pregnancy-risk assessment and minimally ... 2026-07-22T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
NSG Bio Accelerates Breakthrough Biotech Innovation in Singapore New initiative under NSG Bio Tomorrow will support promising startups developing next-generation approaches in respiratory and neonatal care ... 2026-07-22T Biotechnology Computer/Electronics Health Care/Hospital Medical/Pharmaceuticals
Angel Yeast's Initiative Advances Internationally Recognized Codex Standard for baker's yeast YICHANG, China , July 21, 2026 /PRNewswire/ -- The 49th session of the Codex Alimentarius Commission (CAC49), held in Geneva, Switzerland, from July 6 to 10, 2026, adopted a number of international ... 2026-07-21T Biotechnology Food/Beverages Health Care/Hospital
The Second Battlefield for Solid Tumor CAR-T: A Global Race in the Intracranial Arena -- Who Is Leading? T-MAXIMUM PHARMACEUTICAL Inc's Universal CAR-T First-in-Human Data to Debut at the World Conference on Lung Cancer ... 2026-07-21T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Alebund Pharmaceuticals Announces First Participant Randomized and Dosed in Global Phase IIb Multi-Regional Clinical Trial of AP306 for Hyperphosphatemia SHANGHAI , July 21, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; HKEX: 09637), a renal-focused biopharmaceutical company, today announced ... 2026-07-21T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Takeda's Dengue Vaccine (TAK-003) Becomes India's First Approved Dengue Vaccine, Bringing Prevention to One of the World's Most At-Risk Populations The approval comes at a critical time for public health, as reported dengue cases in India have increased 11-fold in the past two decades [1] Takeda's dengue vaccine (TAK-003) is the most extensively ... 2026-07-21T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Haier Biomedical Presents Digital Blood Management Platform at ISBT Congress 2026, Advancing Its Transition from Equipment Provider to Full-Process Solution Partner Driving Digital Transformation in Blood Management for Plasma Collection Centers, Hospitals, and Blood Bank Centers ... 2026-07-21T Biotechnology Computer Software Computer/Electronics Health Care/Hospital
Rege Nephro Secures approximately US$10.6 Million to Advance RN-014 Toward Commercialization Financing will support development of RN-014 and RN-032 and continued expansion of the company's kidney disease pipeline ... 2026-07-21T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
ESMO 2026 \| Mabwell to Present Latest Clinical Data on Nectin-4-targeting ADC 9MW2821 for Triple Negative Breast Cancer in Oral Presentation SHANGHAI , July 21, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, will present the latest clinical study results ... 2026-07-21T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Telix Q2 Revenue US$247M, Strong Momentum and Pipeline Progress MELBOURNE, Australia and INDIANAPOLIS , July 21, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") provides a market update on its commercial and operational ... 2026-07-21T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved